3188 results for cancer and finances
Refine Your Search
Generations of Impact: Ensuring New Cancer Treatments for Those to Come
View on PR Newswire here.
_dam_file_86816.jpg?v=5e3d60b2-4f57-4f8e-a7ff-9196dee73815?crop=true&keep=c&w=400&h=400)
A $100 Million Initiative to Fuel the Next Generation of Cancer Research
View full multimedia release here.
THOUSANDS ACROSS THE NATION TO STEP UP TO TAKE CANCER DOWN
See full multimedia release here
Advancing oral parity because the way we treat cancer has changed
The way we treat cancer has changed. For decades, intravenous (IV) delivery was the primary method for administering the medications used to treat can…
Advocacy
Reining in the cost of cancer care across the healthcare system
With the cost of cancer care rising at an alarming rate, more of the cost burden is shifting to patients, many of whom are then forced to delay or eve…
Advocacy
Blood Cancer United Statement on New NCI Head, Dr. Anthony Letai
Washington, September , —Blood Cancer United®, formerly The Leukemia & Lymphoma Society, applauds the choice of Dr. Anthony Letai to lead the National…
News Release
The Leukemia & Lymphoma Society Denounces Federal Actions that Threaten Cancer Patients
WASHINGTON, February , – As the nation’s largest organization serving the critical needs of blood cancer patients, we are alarmed by recent actions t…
News Release
Multiple Myeloma Patients Cancer Free Five Years after Single CAR-T Treatment
LLS provided critical funding at earliest stages and provides ongoing funding today June , – A new report is opening the possibility that multiple m…
News Release
America’s Youngest Generation is Trailblazing the Way for a Future without Cancer
The Leukemia & Lymphoma Society Announces Winners of National Students of the Year Philanthropic Competition …
Cánceres de la Sangre y COVID-19: Lo que Usted Necesita Saber
Únete a una conversación virtual enfocáda en el impacto de en la comunidad Latina con cáncer de la sangre con los doctores Godley y Rubinstein, dos e…
Cánceres de la Sangre y COVID-19: Lo que Usted Necesita Saber
Únete a una conversación virtual enfocáda en el impacto de en la comunidad Latina con cáncer de la sangre con los doctores Godley y Rubinstein, dos e…
LLS Information Specialists Contribute to Choosing Therapy Article on Cancer & Depression
Sharon Cohan, LCSW and Information Specialist for The Leukemia & Lymphoma Society, states, “One of the biggest myths is that everyone diagnosed with c…
FDA Approves New Drug for Patients with Rare Blood Cancer (Myelofibrosis)
The Food and Drug Administration (FDA) recently approved a drug for the treatment of intermediate or primary or secondary myelofibrosis, the first sp…
News Release
Support Resources
Where Your Ancestors Came From Can Influence Blood Cancer Survival Rates
Scientists are learning more every day about how mutations in an individual's genes can affect their health. But now we’re learning that differences i…
News Release
Making an IMPACT on hematology care in Georgia: The Georgia Blood Cancer Trials Network (BCTN)
Winship Cancer Institute is the only Comprehensive Cancer Center in Georgia, the largest state by land area east of the Mississippi River, and 8th la…
The Role of the DNA Sensor AIM2 in B Cell Fate and Function After HCT
Altered B cell homeostasis plays a key role in the development of chronic (cGVHD) after hematopoietic stem cell transplantation (HCT). We hypothesize…
Toward improvement of BCMA/CST6-CAR-T therapy to target both myeloma cells and bone resorption
We have observed that CST6 proteins suppress osteoclast differentiation and function without causing immunosuppression. We aim to determine whether …
Research: Grants
Burlington Stores and The Leukemia & Lymphoma Society: A Powerful Partnership that Helps to Save Lives
LLS Contact: Kristin Hoose [email protected] Stores Contact: Bari Kurzman212--
Louis J. DeGennaro, Ph.D., Named President and Chief Executive Officer of The Leukemia & Lymphoma Society
Contact: Andrea Greif() [email protected] Plains, NY (September , ) - The Leukemia & Lymphoma Society (LLS) announced today that Louis J.…
Improving Immunotherapy in Multiple Myeloma Through Innovative Clinical Trials, Real-World Evidence and Correlative Research
The overall focus of my research is improving outcomes with immunotherapy in multiple myeloma. I will accomplish this through ) novel clinical trials…
Synthetic introns to target U2AF1 mutant leukemias and dissect molecular basis for mis-splicing
Mutations affecting RNA splicing factors are the most common class of mutations in patients with myelodysplastic syndromes and related myeloid neoplas…
Unraveling the Cellular and Molecular Origins of B-cell Acute Lymphoblastic Leukemia in Down syndrome
Children with Down Syndrome (DS) have a -fold increased risk of Acute Lymphoblastic Leukemia (). We aim to identify the cells of origin in and defin…
Inherited resilience to clonal hematopoiesis and myeloid malignancy by modifying stem cell RNA regulation
This grant proposal aims to uncover inherited resilience to clonal hematopoiesis (CH) and myeloid malignancies (MyMs). Our pilot work has identified a…
Latest FDA Approval in Multiple Myeloma May Reduce Treatment Costs, Frequency and Side Effects
The FDA’s approval of a less frequent treatment regimen in patients with multiple myeloma highlights a trend of making treatments easier for blood can…
News Release
The Grieving Brain: The Surprising Science of How We Learn from Love and Loss
In The Grieving Brain, neuroscientist and psychologist O’Connor gives us a fascinating new window into one of the hallmark experiences of being human…